O Brien Wealth Partners LLC Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

O Brien Wealth Partners LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 56.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 105 shares of the healthcare conglomerate’s stock after selling 138 shares during the quarter. O Brien Wealth Partners LLC’s holdings in UnitedHealth Group were worth $56,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. O Dell Group LLC grew its stake in shares of UnitedHealth Group by 76.9% during the 3rd quarter. O Dell Group LLC now owns 69 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 30 shares during the period. Legend Financial Advisors Inc. bought a new position in UnitedHealth Group during the third quarter worth about $37,000. Investors Research Corp raised its position in shares of UnitedHealth Group by 51.1% in the fourth quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 24 shares during the period. Bourgeon Capital Management LLC grew its stake in UnitedHealth Group by 192.3% in the 4th quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 50 shares in the last quarter. Finally, WFA of San Diego LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $42,000. 86.31% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $484.58, for a total value of $488,456.64. Following the completion of the sale, the executive vice president now directly owns 10,359 shares in the company, valued at $5,019,764.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction dated Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now directly owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,008 shares of the firm’s stock in a transaction that occurred on Friday, April 21st. The shares were sold at an average price of $484.58, for a total transaction of $488,456.64. Following the transaction, the executive vice president now directly owns 10,359 shares of the company’s stock, valued at approximately $5,019,764.22. The disclosure for this sale can be found here. Insiders have sold a total of 8,852 shares of company stock worth $4,313,962 over the last quarter. Corporate insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of recent research reports. Royal Bank of Canada reissued an “outperform” rating and set a $592.00 price objective on shares of UnitedHealth Group in a report on Monday, April 17th. TD Cowen reduced their price objective on shares of UnitedHealth Group from $596.00 to $562.00 and set an “outperform” rating for the company in a research note on Monday, April 17th. Piper Sandler initiated coverage on shares of UnitedHealth Group in a report on Thursday. They issued an “overweight” rating and a $580.00 price target for the company. Cantor Fitzgerald began coverage on UnitedHealth Group in a research report on Thursday, April 20th. They issued an “overweight” rating and a $591.00 price objective on the stock. Finally, Stephens restated an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $599.00.

UnitedHealth Group Trading Up 1.0 %

NYSE:UNH traded up $4.54 during trading hours on Friday, reaching $482.24. The company’s stock had a trading volume of 1,179,652 shares, compared to its average volume of 3,303,649. The firm has a 50-day simple moving average of $489.68 and a 200-day simple moving average of $499.78. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81. UnitedHealth Group Incorporated has a 1 year low of $449.70 and a 1 year high of $558.10. The firm has a market capitalization of $448.98 billion, a price-to-earnings ratio of 21.84, a PEG ratio of 1.39 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH – Get Rating) last issued its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share for the quarter, beating the consensus estimate of $6.24 by $0.02. The company had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a return on equity of 27.05% and a net margin of 6.16%. UnitedHealth Group’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the business posted $5.49 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 24.98 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 21st. Investors of record on Monday, March 13th were issued a dividend of $1.65 per share. The ex-dividend date of this dividend was Friday, March 10th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio is presently 30.18%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.